Thermo Fisher signed an agreement to provide fill and finish manufacturing for "hundreds of millions of doses" of Moderna's COVID-19 vaccine, the drugmakers announced June 1.
Beginning in the third quarter of 2021, Thermo Fisher will produce Moderna's vaccine using its manufacturing plant in Greenville, N.C.
Moderna has contracted other drugmakers to boost its COVID-19 vaccine production, including deals made in April with Sanofi and Catalent.